Innovative Immunotherapy Shows Promise in Early Clinical Trial for Breast Cancer Dec. 5, 2024 — A groundbreaking phase one clinical trial explored a novel cell-based immunotherapy for breast cancer.
but the relative 5-year survival rate is about 2% (distant spread) to 11% (regional spread). What are the warning signs of liver cancer? In the early stages of disease, there are often no symptoms.
Yellow No. 5 is commonly used in brightly colored soda and candy, often to make them appear fresher and more appetizing. Yellow No. 6, which is also used in candy, may appear in salad dressings, ...
Jan. 30, 2025 — A new study shows that artificial intelligence (AI) can help doctors make better decisions when treating cancer. However, it also highlights challenges in how doctors and AI work ...